Mentions
Extended reach
Total likes
Video views
AI synopsis
Multiple discussions highlight the study's main conclusion that high-dose omega-3 fatty acids offer no significant cardiovascular benefits compared to corn oil, with users questioning the utility of omega-3 supplements, as seen in phrases like 'save your $$' and 'no clear benefits'. The tone is predominantly skeptical, with several users expressing frustration over the repeated failures of omega-3 in clinical trials, indicating a shift in sentiment towards a more evidence-based skepticism regarding supplements.
Most discussions reflect a consensus that the study's findings are credible and relevant, with several users expressing no significant benefit from omega-3 compared to corn oil.
There is a noticeable curiosity about the implications of the trial, with many users seeking to understand the results and their relation to previous studies.
Several posts delve into specific aspects of the trial, such as the methodology used and comparisons with other studies, indicating a moderate level of engagement.
Users perceive this trial as having a considerable impact on the ongoing discussion regarding omega-3 fatty acids, suggesting that it challenges prior assumptions about their benefits.
Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3 pills rob the oceans of small fish needed for larger wildlife up the food chain to survive. https://t.co/7u45C5zTwM
JAMA 2020 Estudio STRENGT | Altas dosis de omega 3 vs aceite de maíz en pacientes con alto riesgo cardiovascular RESULTADOS: NO hay diferencia entre aceite de maíz U omega 3 asociados a uso de estatinas para disminuir el riesgo cardiovascular. https://t.co/diqRGK29kI https://t.co/X9143qPB43
Omega üçün kalp damar hastalıklarından korunmada hiç bir işe yaramadığını gösteren ciddi bir çalışma. https://t.co/Thldg2btoU
Omega-3 fatty acids doesn't help to reduce Major adverse cardiovascular events in patients with high cardiovascular risk https://t.co/BUIouh0nUM https://t.co/CkNq9uIR7H
La adición de omega-3, en comparación con el aceite de maíz, a las terapias habituales no produjo una diferencia significativa en eventos cardiovasculares adversos. Estos hallazgos no apoyan el uso para reducir los eventos cardiovasculares. doi:10.1001/jama.2020.22258 https://t.co/UsEpwtdPQ1
“Findings do not support use of this omega-3 fatty acid formulation to reduce major adverse cardiovascular events in high-risk patients” @JAMA_current https://t.co/RQay5g7gvY
This video discusses a significant study assessing the impact of high-dose omega-3 fatty acids on cardiovascular events. The trial involved over 13,000 patients and concluded that omega-3s did not reduce the risk of…
Professor Borge Nordestgaard, a leader in lipidology, discusses hypertriglyceridemia's pathophysiology, diagnosis, and treatment options. The discussion includes insights from recent trials, particularly focusing on…
This episode discusses recent clinical trial results evaluating whether omega 3 supplements benefit high-risk cardiovascular patients, focusing on the impact of icosapent ethyl in reducing cardiovascular events and…
This segment reviews the 12 key nephrology and hypertensiology studies of 2025, including recent findings on kidney health in diabetes, treatment advancements, and emerging therapies like GLP-1 receptor agonists and…
RT @Fizz_DI: 心血管リスクの高い患者のスタチン治療に対する「EPA+DHA」の追加は、プラセボ（コーン油）に比べて心血管イベントを抑制しなかった、というRCT。 ・主要心血管イベント：HR=0.99 [95%CI: 0.90-1.09] JAMA.324(22)…
RT @Fizz_DI: 心血管リスクの高い患者のスタチン治療に対する「EPA+DHA」の追加は、プラセボ（コーン油）に比べて心血管イベントを抑制しなかった、というRCT。 ・主要心血管イベント：HR=0.99 [95%CI: 0.90-1.09] JAMA.324(22)…
心血管リスクの高い患者のスタチン治療に対する「EPA+DHA」の追加は、プラセボ（コーン油）に比べて心血管イベントを抑制しなかった、というRCT。 ・主要心血管イベント：HR=0.99 [95%CI: 0.90-1.09] JAMA.324(22):2268-2280,(2020) PMID:33190147 https://t.co/D3gl38EpWK
@DrBenAnsell @DLBHATTMD @drpablocorral @gabrielsteg Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk The STRENGTH Randomized Clinical Trial JAMA. 2020;324(22):2268-2280. doi:10.1001/jama.2020.22258
RT @keisuke4713: 高用量ω3脂肪酸と
高用量ω3脂肪酸と
1) N Engl J Med . 2019 Jan 3;380(1):11-22. https://t.co/oL9UtgtALV 3) JAMA . 2020 Dec 8;324(22):2268-2280. https://t.co/D3gl38EpWK ↑どっちも海外の高用量（4,000mg）の話だし、でこれまで流し気味だったけど、↓国内の1,800mgのRCTでも同じ傾向が出てきて、確かにﾑﾑﾑ…となっている
RT @tak_pom: Stephen J. Nicholls,et al. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Pati…
@ATallMountain @realDaveFeldman @TuckerGoodrich @raphaels7 There is a ton of research on useless things. The O3 hype has been debunked many times. No use of O3 vs. O6, see strength trial below. If you don't know or cannot confirm effects of AA, you should not be debating it. https://t.co/SWF5kzqY15
Baseline levels are usually quite high in many of these trials — for instance, baseline in #STRENGTH was almost 6% O3I… that’s not depleted and actually sufficient and assumes fish intake at baseline https://t.co/vzTsSpWTlO
@jon_alessi @Drlipid PUFA in general lower apoB, but neither fish nor fish oil seem to. In the STRENGTH trial, LDL-C omega-3 *increased* LDL-C https://t.co/S6giWyoBuq This meta-analysis finds that omega-3 fatty acids had no effect on LDL-C (WMD 0.03 [—0.08 to 0.15]). https://t.co/0XfFupYD3d
@foundmyfitness "A greater rate of gastrointestinal adverse events was observed in the omega-3 CA group (24.7%) compared with corn oil-treated patients (14.7%)." https://t.co/SWF5kzqY15
@Andre_tuit Ojo con las interpretaciones del Omega-3. No es una píldora mágica. A veces es más marketing de largo plazo…. https://t.co/lbVNklLd62
19/
@twitevit Yes, supplements, high-dose purified omega-3 vs. corn oil. https://t.co/FHAxsqSG1f
@TheBrainBattery @Mangan150 No benefit of high dose omega-3 vs. corn oil in Strength trial. https://t.co/FHAxsqSG1f
@philosophising4 @DrDorotaSK @dannibo123 @JuliaB_fitness @yeeseak @KiesowPaul Meta-analysis of randomized controlled trials, the best evidence available, Do not support omega-3 supplementation. Here again a link to the Strength trial that proves no benefit of omega-3 over omega-6. https://t.co/FHAxsqSG1f
@KristerKauppi @philosophising4 @ValEr65611963 @yeeseak @JuliaB_fitness @GKeeto @shunyata2000 @KiesowPaul @JaredMichaels17 @mkaeberlein @agingdoc1 @aubreydegrey https://t.co/CeAMATDfmI
@jasondhoward83 @NutritionMadeS3 The Strength trial compared high-dose omega-3 vs. corn oil (omega-6) and found no difference. https://t.co/FHAxsqTdQN
RT @tak_pom: Stephen J. Nicholls,et al. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Pati…
@ElNutriDice Y dime instituciones de prestigio que los desaconsejan, por favor. Espero los leas, busques el consenso mundial y me digas que no estss haciendo un Bayter https://t.co/Iu4jRAq5B8 https://t.co/U4rcvZ2b8b https://t.co/MMxtGi2owp
@ElNutriDice https://t.co/MMxtGijryp
Stephen J. Nicholls,et al. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial JAMA. 2020 Dec 8; 324(22): 2268–2280. https://t.co/eyWAdUO6eH
@hmkyale What are your thoughts on the comparator placebo in the strength trial? https://t.co/DWDC8I4c4V Should we do a 2:2 trial of Corn oil Vs Mineral oil and Vascepa Vs Epanova @DLBHATTMD Vs @ProfSNicholls
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk The STRENGTH Randomized Clinical Trial https://t.co/kJXyNJ8Pts
STRENGTH Trial Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk https://t.co/Ixo3YhWXIH https://t.co/BpV7mmuGDu
何気にノーマークった。 Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Card… https://t.co/GGUZSjm7lV
@NanciGuestRDPhD @Veganella_ @JackNorrisRD @Plant_proof @JessLReid @NutritionMadeS3 @AJagim @Tom_Babington1 @NutritionDanny I see. Do you have more plausible mechanisms in mind? It's hard for me to imagine such a small amount of unsaturated fat once inside the body having as big a negative effect as the gut issues found in trials like these (with high dose pure EPA/DHA): https://t.co/rbHBHfwVNe
RT @ChristineSalzer: @bayer je kleiner das unternehmen umso wichtiger die finanzierung? #genmais #monsanto https://t.co/EqZikjK6hA https:/…
@bayer je kleiner das unternehmen umso wichtiger die finanzierung? #genmais #monsanto https://t.co/EqZikjK6hA https://t.co/i5nx8RBRMx
https://t.co/V5hRQ7mF5t Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk The STRENGTH Randomized Clinical Trial REDUCE-ITが書かれてるから、これもネガティブだよ！で書かれる？
Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/ugBjQKmpID via @jamaophth #MineralSupplements #healthsupplements #multivitamins #Probiotics
Estudo multicêntrico e duplo-cego com 13078 pacientes de alto risco cardiovascular já em uso de estatina, randomizados para receber 4g/dia de suplementos de Ômega 3 vs placebo (óleo de milho). https://t.co/DCn3r0Eyge
@DavidClinkard @hjluks For the overall issues, overall context https://t.co/bQBLsjAd7m With reference to STRENGTH https://t.co/mJD8D6dJgh & commentary: https://t.co/i8gewYcXpL
Omega-3 has no clear benefits? https://t.co/HY7JkWJuoW
RT @PabloRichly: Para prevención cardiovascular sería lo mismo tomar un suplemento con omega 3 que tomar aceite de maíz. https://t.co/aYel…
@PabloRichly @DLBHATTMD REDUCE-IT se publicó en 2019 https://t.co/FYwrgwr4DZ STRENGTH se detuvo precozmente por futilidad y se publicó en 2020 https://t.co/vP1XoA8o76 Lo que se presentó hoy y está publicado simultáneamente es un subanalisis del STRENGTH https://t.co/jfPJlg9bGv Esta todo publicado
Among statin-treated patients at high CV risk, the addition of high-dose omega-3 fatty acid resulted in no significant difference in MACE: The STRENGTH Randomized Clinical Trial | JAMA Network https://t.co/WiDwLBDz4J
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. https://t.co/kvwwG1aRrX https://t.co/uI50oa8X7q
心血管リスクが高い患者へスタチン治療にEPAおよびDHA（オメガ‐3CA）を加えてもMACEを減らさなかった。 https://t.co/gpodbcDrXM
Omega-3-fedtsyrer menes være "godt for hjertet", men i dette store randomiserede forsøg, hvor de blev sammenlignet med majsolie, mindskede de ikke risikoen for hjertekarsygdom, men øgede i stedet risikoen for mave-tarmbivirkninger. #dklæger #dkmedier https://t.co/Rum2kBsBWx
Chronic use of omega-3 Fatty Acids not beneficial for cardiovascular prevention in statin treated patients and some hints it might increase the incidence of atrial fibrillation. Advice your patient https://t.co/CingJfaSXj
بالاخره ثابت شد امگا ٣ اونقدرها هم موثر نيست https://t.co/wftmkGV5LT
In this RCT, #omega3 fatty acids (EPA/DHA) did not reduce major adverse CV events vs corn oil in statin-treated patients at high CV risk (compare w Vascepa in REDUCE-IT) https://t.co/0Uqi7bKfz2 @LincoffMichael @ProfSNicholls @ClevelandClinic #STRENGTHTrial #AHA20 #SteveNissen
Omega 3 Fatty Acids Fail to Deliver Their Initial Promise This new study recapitulates a theme common to reductionistic western science which gives only an incremental and partial view of truth. So, it takes much time and effort to reveal the whole story https://t.co/j8mbvbC1ly
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
'These findings do not support use of this omega-3 fatty acid formulation to reduce major adverse cardiovascular events in patients with high cardiovascular risk.' https://t.co/LWqnjAqSiE
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
omega-3 yağ asitlerini tablet şeklinde kullanmak, kalp hastalıklarına karşı koruma sağlamıyor. Doğal hafta iki kez yağlı balık tüketmek önerilir https://t.co/S5hkUQviJD
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @TamarHaspel: New evidence that omega-3 fats don't reduce heart attack risk. A big trial (n=13k+) comparing EPA/DHA to corn oil finds n…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @TamarHaspel: New evidence that omega-3 fats don't reduce heart attack risk. A big trial (n=13k+) comparing EPA/DHA to corn oil finds n…
The importance of understanding and questioning “the whole picture” Prior to taking any research publication as “gold”, we have to ponder the limitations (which leads to more questions and future research). We all have to continue improving this skill! https://t.co/APfwS2mMVT https://t.co/uSZyuQC5ZA
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
RT @bigfatsurprise: Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3…
Save your $$. This is the 4th trial at least showing no cardiac benefit from taking omega 3 supplements. Plus those o3 pills rob the oceans of small fish needed for larger wildlife up the food chain to survive. https://t.co/7u45C5zTwM
RT @TamarHaspel: New evidence that omega-3 fats don't reduce heart attack risk. A big trial (n=13k+) comparing EPA/DHA to corn oil finds n…
RT @TamarHaspel: New evidence that omega-3 fats don't reduce heart attack risk. A big trial (n=13k+) comparing EPA/DHA to corn oil finds n…
RT @TamarHaspel: New evidence that omega-3 fats don't reduce heart attack risk. A big trial (n=13k+) comparing EPA/DHA to corn oil finds n…
RT @XBayona: “Findings do not support use of this omega-3 fatty acid formulation to reduce major adverse cardiovascular events in high-risk…
RT @XBayona: “Findings do not support use of this omega-3 fatty acid formulation to reduce major adverse cardiovascular events in high-risk…
RT @XBayona: “Findings do not support use of this omega-3 fatty acid formulation to reduce major adverse cardiovascular events in high-risk…
RT @XBayona: “Findings do not support use of this omega-3 fatty acid formulation to reduce major adverse cardiovascular events in high-risk…
RT @XBayona: “Findings do not support use of this omega-3 fatty acid formulation to reduce major adverse cardiovascular events in high-risk…
RT @XBayona: “Findings do not support use of this omega-3 fatty acid formulation to reduce major adverse cardiovascular events in high-risk…
RT @XBayona: “Findings do not support use of this omega-3 fatty acid formulation to reduce major adverse cardiovascular events in high-risk…
New evidence that omega-3 fats don't reduce heart attack risk. A big trial (n=13k+) comparing EPA/DHA to corn oil finds no protective effect. https://t.co/1zZTIMV27g
https://t.co/KVKspf1bys As usual this rather misses the point. You can't recover health by "taking a pill" extra. You can get HDL up and Trigs down by adopting a real food low carb. diet that also includes good quality Om 3 because its part of some great nutrient dense foods.
“Findings do not support use of this omega-3 fatty acid formulation to reduce major adverse cardiovascular events in high-risk patients” @JAMA_current https://t.co/RQay5g7gvY
JAMA omega-3脂肪酸を用いた心血管イベントをアウトカムとしたRCT 対象：心血管ハイリスク 介入：4g EPA/DHA placebo：コーンオイル 結果：心血管イベントに全く有意差なし ポジディブな結果であるREDUCE-IT試験とは、placebo（鉱油）の違いなどあるが、ここまで差が出るか https://t.co/4eEHRNWfzs
Findings @JAMA_current do not support the benefit of omega-3 fatty acids for reducing adverse cardiovascular events in high-risk patients. @AboutHerbs PubMed link: https://t.co/dRl3yKCHAk
No evidence for omega 3 supplementation in those at high cardiovascular risk, now out in JAMA The STRENGTH Randomized Clinical Trial https://t.co/nV57LXRmTo
RT @JAMA_current: In this RCT, #omega3 fatty acids (EPA/DHA) did not reduce major adverse CV events vs corn oil in statin-treated patients…
Given recent posts regarding statin's impact, and that so many patients resist taking statins... https://t.co/7m2quhW1PD What do YOU think?
RT @JAMA_current: In this RCT, #omega3 fatty acids (EPA/DHA) did not reduce major adverse CV events vs corn oil in statin-treated patients…
RT @JAMA_current: In this RCT, #omega3 fatty acids (EPA/DHA) did not reduce major adverse CV events vs corn oil in statin-treated patients…
In this RCT, #omega3 fatty acids (EPA/DHA) did not reduce major adverse CV events vs corn oil in statin-treated patients at high CV risk (compare w Vascepa in REDUCE-IT) https://t.co/vzgYTRN8YL @LincoffMichael @ProfSNicholls @ClevelandClinic #STRENGTHTrial #AHA20 #SteveNissen
EPAよ… Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Card… https://t.co/gpodbcDrXM
コーン油はCVDイベントを含む複合アウトカムの発生率に差はなかったhttps://t.co/fLR4bVuRvK
#DHA #EPA #Omega3, Evaluated by #RCT. Results to mourn, No better than corn.
These findings do not support use of this omega-3 fatty acid formulation to reduce major adverse cardiovascular events in patients with high cardiovascular risk. The STRENGTH Randomized Clinical Trial | Cardiology | JAMA | JAMA Network https://t.co/nh4aPmCcaM
RT @SABOURETCardio: #EPA #DHA NO Class Effect for omega 3 fish-oils. #cardiotwitter. The STRENGTH Randomized Clinical Trial | Cardiology |…
RT @EUGsurf: Ácidos grasos #omega-3 NO disminuyen eventos cardiovasculares mayores respecto al aceite de maíz, en pacientes con alto riesgo…
Ácidos grasos #omega-3 NO disminuyen eventos cardiovasculares mayores respecto al aceite de maíz, en pacientes con alto riesgo CV tratados con estatinas. Ensayo clínico #strength, vía @JAMA_current https://t.co/R00eBQedLI #fisioterapia #nutricion #investigacion #traslacional https://t.co/Vnw3cF4lyg
RT @JAMA_current: In this RCT, omega-3 fatty acids (EPA/DHA) did not reduce major adverse CV events vs corn oil in statin-treated patients…
RT @FarmaMadridAP: (JAMA) En pacientes con estatinas y alto riesco CV, la adición de omega-3 en comparación con el aceite de maíz, no pr…
(JAMA) En pacientes con estatinas y alto riesco CV, la adición de omega-3 en comparación con el aceite de maíz, no produjo una diferencia significativa en los eventos CV importantes. EC STRENGTH https://t.co/OQNIiyrjjS
RT @JAMA_current: In this RCT, omega-3 fatty acids (EPA/DHA) did not reduce major adverse CV events vs corn oil in statin-treated patients…
Another study from JAMA questioned the effect of omega-3 fatty acid on cardiovascular disease https://t.co/JXs7lClp2Z
RT @DineshJillella: STRENGTH Vs. REDUCE-IT RCTs for cardiovascular benefit using high dose-EPA. STRENGTH not showing the excellent outcom…
RT @cupallcare: Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/LTlKlZHKx7 vi…
Omega-3 Fatty Acids in statin treated patients with high TG ans low HDL- The #STRENGTH Trial shows they don’t do much- anyone still think there is a place? I recommend eating oily fish if they want to, rather than supplements ... https://t.co/pfIlalpiv3
STRENGTH Vs. REDUCE-IT RCTs for cardiovascular benefit using high dose-EPA. STRENGTH not showing the excellent outcomes as seen with REDUCE-IT. Did Placebo choice play a role? Will this be the new FLAME Vs. FOCUS (+AFFINITY and EFFECTS) scenario? https://t.co/Gqhmu9hvEG
RT @paolabel_cardio: Otro estudio negativo sobre prevencion CV con Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events…
Otro estudio negativo sobre prevencion CV con Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/5uO6fCtcIO a través de @JAMA_current part of @JAMANetwork
Malades sous statines : pas d'intérêt d'une supplémentation en oméga-3, sauf sur le taux de triglycérides https://t.co/7jpAtxc3av
RT @MediCasos: JAMA 2020 Estudio STRENGT | Altas dosis de omega 3 vs aceite de maíz en pacientes con alto riesgo cardiovascular RESULTADOS…
RT @MediCasos: JAMA 2020 Estudio STRENGT | Altas dosis de omega 3 vs aceite de maíz en pacientes con alto riesgo cardiovascular RESULTADOS…
Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/wJ983iYQ8m via @JAMA_current part of @JAMANetwork
https://t.co/2FRoJDm01v スタチン投与を受けている患者に対し、EPAやDHAを加えると心血管系ベントが減るかを調べたRCT 結果は、臨床有益性が低いため途中で中止された。途中解析では、イベントは介入群で12.0%、対照群で12.2%だった(HR:0.99[0.91-1.09]) #当麻_肝・栄養
RT @MediCasos: JAMA 2020 Estudio STRENGT | Altas dosis de omega 3 vs aceite de maíz en pacientes con alto riesgo cardiovascular RESULTADOS…
JAMA 2020 Estudio STRENGT | Altas dosis de omega 3 vs aceite de maíz en pacientes con alto riesgo cardiovascular RESULTADOS: NO hay diferencia entre aceite de maíz U omega 3 asociados a uso de estatinas para disminuir el riesgo cardiovascular. https://t.co/diqRGK29kI https://t.co/X9143qPB43
Trending on PubMed: Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. https://t.co/H0cf4L9OYy
Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/LTlKlZHKx7 via @JAMA_current part of @JAMANetwork
RT @ChooseWiselyBR: Ômega 3 & Prevenção Cardiovascular Em 2019, nosso @LuisCLCorreia havia se posicionado assim: https://t.co/WtddDHc7xQ...…
RT @ErnMedBlog: Häufig behauptet: #Omega3 in Studien nur deshalb ohne Effekt, weil unterdosiert. Neue randomisiert-kontrollierte Studie (n=…
RT @LSchwingshackl: Large RCT in @JAMA_current No Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Even…
Ômega 3 & Prevenção Cardiovascular Em 2019, nosso @LuisCLCorreia havia se posicionado assim: https://t.co/WtddDHc7xQ... Partia de um estudo positivo, mas clamava pelo paradigma da reprodutibilidade. Saiu agora novo ECR: https://t.co/X8FnyAHrYv. Negativo!
RT @rincondesisifo: (JAMA) El suplemento con ácidos grasos omega 3 en personas de ↑riesgo CV no disminuye los eventos CV https://t.co/Ks2V6…
RT @ErnMedBlog: Häufig behauptet: #Omega3 in Studien nur deshalb ohne Effekt, weil unterdosiert. Neue randomisiert-kontrollierte Studie (n=…
RT @AMAManual: Seems reasonable. Tackled this yesterday in JAMA (https://t.co/lMx8eHLjlx).
RT @LSchwingshackl: Large RCT in @JAMA_current No Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Even…
RT @rincondesisifo: (JAMA) El suplemento con ácidos grasos omega 3 en personas de ↑riesgo CV no disminuye los eventos CV https://t.co/Ks2V6…
RT @ErnMedBlog: Häufig behauptet: #Omega3 in Studien nur deshalb ohne Effekt, weil unterdosiert. Neue randomisiert-kontrollierte Studie (n=…
RT @rincondesisifo: (JAMA) El suplemento con ácidos grasos omega 3 en personas de ↑riesgo CV no disminuye los eventos CV https://t.co/Ks2V6…
(JAMA) El suplemento con ácidos grasos omega 3 en personas de ↑riesgo CV no disminuye los eventos CV https://t.co/Ks2V6B26YS ECA https://t.co/qMK4Q29JzX
Häufig behauptet: #Omega3 in Studien nur deshalb ohne Effekt, weil unterdosiert. Neue randomisiert-kontrollierte Studie (n=13.078) zeigt: Selbst hoch dosierte Omega3 mit erhöhter Bioverfügbarkeit sind ohne kardiologischen Vorteil bei Hochrisikopatienten. https://t.co/SKTiDMaxfG
(JAMA) En pacientes tratados con estatinas con ⬆️ riesgo CV, la adición de omega-3, en comparación con el aceite de maíz, a las terapias de base habituales no produjo una diferencia significativa en un resultado combinado de eventos CV adversos importantes https://t.co/OQNIiy9HVi
Large RCT in @JAMA_current No Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk https://t.co/05O2jUIsXA https://t.co/ZEVW4wHDaS
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial | Cardiology | JAMA | JAMA Network https://t.co/uySVzo00NX
RT @DrNorteno: La adición de omega-3, en comparación con el aceite de maíz, a las terapias habituales no produjo una diferencia significati…
La adición de omega-3, en comparación con el aceite de maíz, a las terapias habituales no produjo una diferencia significativa en eventos cardiovasculares adversos. Estos hallazgos no apoyan el uso para reducir los eventos cardiovasculares. doi:10.1001/jama.2020.22258 https://t.co/UsEpwtdPQ1
An omega-3 formulation of eicosapentaenoic acid and docosahexaenoic acid was not associated with a reduction in cardiovascular events in high-risk patients. https://t.co/3Q0pfew56g
@PeterAttiaMD I came across this study. I'm curious what your thoughts are given your previous conversation with Bill Harris on this topic. https://t.co/zfrdtuOYNk
Tu corazón y el Omega-3 Acaban de ser publicados los resultados del estudio “The STRENGH Randonmized Clinical Trial” y se encontró que altas dosis de ácidos grasos Omega-3 no reduce los eventos cardiovasculares en pacientes de alto riesgo.doi:10.1001/jama.2020.22258
RT @Office_j: https://t.co/8S09PQ8hId 類似対象でポジティブだったREDUCE-ITでは、EPA 4g/日 vs. 鉱油。STRENGTH研究者は、鉱油を対照とした適切性を疑問視 [対照群でCRP上昇] 。
RT @Office_j: https://t.co/8S09PQ8hId 類似対象でポジティブだったREDUCE-ITでは、EPA 4g/日 vs. 鉱油。STRENGTH研究者は、鉱油を対照とした適切性を疑問視 [対照群でCRP上昇] 。
RT @CaulfieldTim: #Omega3 Fatty Acids & Cardiovascular Events https://t.co/CuuwkHi60w via @JAMA_current @JAMANetwork #supplements Sum: "Th…
RT @Office_j: https://t.co/8S09PQ8hId 類似対象でポジティブだったREDUCE-ITでは、EPA 4g/日 vs. 鉱油。STRENGTH研究者は、鉱油を対照とした適切性を疑問視 [対照群でCRP上昇] 。
STRENGTH trial: omega-3 CA vs corn oil for CVD: hazard ratio, 0.99 [95% CI, 0.90-1.09]; P =0 .84. Yikes! Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/fVEcaY9fNg via @JAMA_current part of @JAMANetwork
https://t.co/8S09PQ8hId 類似対象でポジティブだったREDUCE-ITでは、EPA 4g/日 vs. 鉱油。STRENGTH研究者は、鉱油を対照とした適切性を疑問視 [対照群でCRP上昇] 。
#Omega3Fettsäuren senken, im Vergleich zu Mais-Öl, das Herz-Kreislaufrisiko bei Risikopatienten nicht https://t.co/vk4qp6O694 mehr lesen (in englischer Sprache) Quelle:JAMA 15.11.20
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial | Cardiology | JAMA | JAMA Network. Learning from the best: results of a 13000 RCT https://t.co/Q5CbLAGY0F
RT @usg_ringo: 食品安全情報blog2「論文:心血管系リスクの高い患者での主要有害心血管系イベントに与える高用量オメガ3脂肪酸対コーン油」https://t.co/3ZzRM01dze ”https://t.co/bggP2HYnqH 13078人の患者でのRCT…
あららら、、、 ω-3脂肪酸は、食用油(コーン油)に比してハイリスク患者の心血管イベントを減らさない。 Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/3jGTpNNeSr @JAMA_current part of @JAMANetworkより
食品安全情報blog2「論文:心血管系リスクの高い患者での主要有害心血管系イベントに与える高用量オメガ3脂肪酸対コーン油」https://t.co/3ZzRM01dze ”https://t.co/bggP2HYnqH 13078人の患者でのRCTは、有害心血管系イベントの複合アウトカムへの意味のある差が無かったため早期に終了した。”⇒
RT @NanciGuestRDPhD: #New Another failed trial: #HeartHealth
RT @ProfKausikRay: Our paper out now in JAMA . Lots to discuss heh https://t.co/fJRbtcdvTw
RT @ProfSNicholls: Thanks to all the patients and investigators in the STRENGTH study. Omega-3 Fatty Acids vs Corn Oil and Major Adverse Ca…
RT @gbiondizoccai: "Among statin-treated patients at high cardiovascular risk, the addition of omega-3 CA, compared with corn oil, to usual…
#AHA20 – Randomized trial: High-dose Omega-3 fatty acids did not reduce the risk of cardiac events in patients at high cardiovascular risk – via @JAMA_current https://t.co/DWV9eoiRIE Editorial 1: https://t.co/xIOFg2ciB6 Editorial 2: https://t.co/cNIU1s762a
RT @CaulfieldTim: #Omega3 Fatty Acids & Cardiovascular Events https://t.co/CuuwkHi60w via @JAMA_current @JAMANetwork #supplements Sum: "Th…
#Omega3 Fatty Acids & Cardiovascular Events https://t.co/CuuwkHi60w via @JAMA_current @JAMANetwork #supplements Sum: "These findings do not support use of this omega-3 fatty acid formulation to reduce major adverse cardiovascular events in patients with high cardiovascular risk.
RT @ProfKausikRay: Our paper out now in JAMA . Lots to discuss heh https://t.co/fJRbtcdvTw
RT @gbiondizoccai: "Among statin-treated patients at high cardiovascular risk, the addition of omega-3 CA, compared with corn oil, to usual…
NVM, I found it! https://t.co/8IiDQh7FmJ
E agora, @sbc_cientifico? https://t.co/VdkWWbuDK0
RT @SWexner: Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/BMt434hKps via @…
Entre los pacientes tratados con estatinas con alto riesgo cardiovascular, la adición de omega-3 CA, en comparación con el aceite de maíz, no produjo una diferencia significativa en un resultado combinado de eventos cardiovasculares adversos importantes https://t.co/JqqQzOIBYu
#New Another failed trial: #HeartHealth
RT @cupallcare: Omega-3 is just Cod Liver Oil by a different name Will go by the way side and save your money @cupallcare @cuonline Omega-3…
Omega-3 is just Cod Liver Oil by a different name Will go by the way side and save your money @cupallcare @cuonline Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/NCWQ8BMY8w via @JAMA_current part of @JAMANetwork
Seems reasonable. Tackled this yesterday in JAMA (https://t.co/lMx8eHLjlx).
RT @DiegoBellido2: Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/0wVPMf197b…
No benefit of 4 g/d mixed DHA/EPA. In comparison, REDUCE-IT, used 4 g/d of pure EPA. https://t.co/YLO6qQATDx via @JAMA_current part of @JAMANetwork
RT @MeralKayikcoglu: Omega-3 vs CornOil no difference in MACE in Pts at HighRisk https://t.co/T5ZTClHOmg via @JAMA_current @JAMANetwork @La…
RT @MeralKayikcoglu: Omega-3 vs CornOil no difference in MACE in Pts at HighRisk https://t.co/T5ZTClHOmg via @JAMA_current @JAMANetwork @La…
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial | Cardiology | JAMA | JAMA Network https://t.co/O1ujMiCz88
RT @DiegoBellido2: Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/0wVPMf197b…
RT @WesElyMD: Fish Oil for ❤️ Dz? JAMA People spend $4B/yr! N=13,000 pts, 675 sites, 22 countries. 4 g/d of #Omega-3 Fatty Acids EPA+DHA…
Fish Oil for ❤️ Dz? JAMA People spend $4B/yr! N=13,000 pts, 675 sites, 22 countries. 4 g/d of #Omega-3 Fatty Acids EPA+DHA vs. Corn Oil (control). No ⬇️ in CV risk, Versus N=8,000 “+” REDUCE-IT Trial of EPA alone. Need tiebreaker. https://t.co/Mm0aNCHVZ0 #medtwitter #meded https://t.co/JXGnrAmP2b
RT @ProfSNicholls: Thanks to all the patients and investigators in the STRENGTH study. Omega-3 Fatty Acids vs Corn Oil and Major Adverse Ca…
RT @JAMA_current: In this RCT, omega-3 fatty acids (EPA/DHA) did not reduce major adverse CV events vs corn oil in statin-treated patients…
High dose Omega 3 does not improve cardiovascular health https://t.co/WtbTDL4FV1
Feels like an endless story/debate Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/qCf0PSp9uY via @JAMA_current part of @JAMANetwork
RT @ProfKausikRay: Our paper out now in JAMA . Lots to discuss heh https://t.co/fJRbtcdvTw
RT @JAMA_current: In this RCT, omega-3 fatty acids (EPA/DHA) did not reduce major adverse CV events vs corn oil in statin-treated patients…
RT @ProfKausikRay: Our paper out now in JAMA . Lots to discuss heh https://t.co/fJRbtcdvTw
RT @ProfKausikRay: Our paper out now in JAMA . Lots to discuss heh https://t.co/fJRbtcdvTw
RT @JAMA_current: In this RCT, omega-3 fatty acids (EPA/DHA) did not reduce major adverse CV events vs corn oil in statin-treated patients…
RT @gbiondizoccai: "Among statin-treated patients at high cardiovascular risk, the addition of omega-3 CA, compared with corn oil, to usual…
RT @aussiecoley: Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/F3AIlGdOln v…
Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/F3AIlGdOln via @JAMA_current part of @JAMANetwork
"Among statin-treated patients at high cardiovascular risk, the addition of omega-3 CA, compared with corn oil, to usual background therapies resulted in no significant difference in a composite outcome of major adverse cardiovascular events" https://t.co/CWUeqeCJk8 https://t.co/IYo518VRGx
En pacientes c/alto riesgo CV tratados c/estatinas, la adición de una formulación de ácido carboxílico de ácidos grasos omega-3 a las terapias usuales no tendría diferencia en los eventos CV adversos mayores https://t.co/C0Yy7MLH66 a través de @JAMA_current part of @JAMANetwork
RT @ProfKausikRay: Our paper out now in JAMA . Lots to discuss heh https://t.co/fJRbtcdvTw
RT @ProfKausikRay: Our paper out now in JAMA . Lots to discuss heh https://t.co/fJRbtcdvTw
RT @FormigaFrancesc: Omega-3 Fatty Acids vs Corn Oil and Major Adverse Cardiovascular Events in Patients at High Risk https://t.co/PO2KkMoy…
RT @ProfKausikRay: Our paper out now in JAMA . Lots to discuss heh https://t.co/fJRbtcdvTw
RT @ProfKausikRay: Our paper out now in JAMA . Lots to discuss heh https://t.co/fJRbtcdvTw
Omega üçün kalp damar hastalıklarından korunmada hiç bir işe yaramadığını gösteren ciddi bir çalışma. https://t.co/Thldg2btoU
STRENGTH trial: In Pts. at ⬆️CV risk, on maximally-tolerated statin, ⬆️TG & ⬇️HDL, no difference between omega-3 CA (EPA & DHA) 4 g/day vs. corn oil for MACE at 38.2 months. ⬆️new-onset AFib (ARI 0.9%) & ⬆️GI upset with omega-3 CA. https://t.co/DzmcjrB5jG https://t.co/Nq8oqA8SAT
Hard to understand but the data is the data-Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial | Cardiology | JAMA | JAMA Network https://t.co/p5rS7Jn2Kf
RT @ph_minimal: Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascul…
RT @danielisazamd: Vamos a necesitar un estudio de placebo vs placebo? mineral oil vs corn oil !
The findings of this study do not support use of omega-3 fatty acid formulation in reducing major adverse cardiovascular events in patients with high cardiovascular risk. @JAMA_current https://t.co/HRJdEef5x3
RT @ProfKausikRay: Our paper out now in JAMA . Lots to discuss heh https://t.co/fJRbtcdvTw
Vamos a necesitar un estudio de placebo vs placebo? mineral oil vs corn oil !
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial | Cardiology | JAMA | JAMA Network この規模でコーン油とぜんぜん差がないんですね… https://t.co/OendvxakRi
https://t.co/yqsUP5ZEQU Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk The STRENGTH Randomized Clinical Trial https://t.co/ntuecYHWCQ
Omega-3 fatty acids doesn't help to reduce Major adverse cardiovascular events in patients with high cardiovascular risk https://t.co/BUIouh0nUM https://t.co/CkNq9uIR7H